GlobeNewswire

New ORM Benchmark Identifies Wolters Kluwer’s Enablon and eVision as Leaders in Operational Risk Management

Share

Independent research firm recognizes best-in-class user experience and strong ORM and safety functionalities

CHICAGO and PARIS, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Independent research firm Verdantix has recognized eVision and Enablon as leaders in the growing Operational Risk Management (ORM) market, in the first ever benchmark of ORM software vendors. The report recognizes Wolters Kluwer’s Enablon and eVision for having the strongest market momentum in the industry.

Enablon and eVision joined forces in October 2018 after eVision’s acquisition by Wolters Kluwer. Together, they address customers’ needs for a holistic process for control of environmental, health & safety and operational risks.

The Verdantix Green Quadrant Operational Risk Management Software 2019 sees the complementarity of both solutions as a strong asset, offering a broad range of functionalities. Verdantix also notes that together, Enablon and eVision scored highest among 17 companies in 16 of the 30 assessed capabilities, including:

  • Platform User Interface (Enablon), a rare perfect score
  • Alternative User Interface (eVision), offering digital diagrams ad geospatial mapping
  • Platform Design (Enablon)
  • Process Safety Management (Enablon), including modules for compliance audits, incident management, emergency response, management of change, pre-start-up safety management and process hazard analysis
  • Job Hazard Analysis (eVision)
  • Isolation Management (eVision)
  • Permit to Work (eVision)
  • Mechanical Integrity (Enablon)

“We are very pleased to be named leaders in the Operational Risk Management software market,” says Chris Joseph, CEO of Enablon and eVision. “Our combined strengths and global reach make Enablon and eVision extremely well-placed to support customers in asset-intensive and high-risk industries. With our software, they are able to cover all risk, safety, and compliance programs and workflows, from the corporate level, down to the operational plant level and even the individual asset and worker.”

“It is an exciting time to be in this industry. Technology offers us the possibilities to transform the way risks are managed: from reporting to predicting and preventing incidents in real-time. Innovation is at the core of both our businesses. We will continue to leverage the latest digital trends such as advanced analytics and Artificial Intelligence to help our customers increase operational excellence, avoid environmental accidents and ensure the safety of their workforce,” says Joseph.

The easy-to-use and highly configurable eVision and Enablon software platforms are available in the cloud and on-premise, depending on customers’ requirements.

About Verdantix & the Green Quadrant 

Verdantix is an independent research and consulting firm with expertise in environment, health, safety, operational risk management and quality as well as energy, real estate, facilities and maintenance. Based on proprietary Verdantix Green Quadrant methodology, the analysis combines benchmark data from two-hour live product demonstrations, responses to a 211-point questionnaire and interviews with 16 customers. The report provides a detailed fact-based comparison of the 17 most prominent operational risk management software suppliers globally.

About Wolters Kluwer 

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services. Wolters Kluwer reported 2017 annual revenues of €4.4 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.  

Enablon, a Wolters Kluwer business, is the world’s leading provider of EHS, Operational Risk Management and Sustainability Software. Hundreds of global companies and 1 million users rely on Enablon software solutions to manage their environmental and social performance, minimize risks and improve profitability. Enablon offers the most comprehensive platform in the industry and is consistently recognized as a global leader and visionary. For more information about Enablon: www.enablon.com.

eVision, a Wolters Kluwer business since 2018, builds powerful solutions that enable customers to realize breakthroughs in safety and efficiency. The ONE Vision Platform offers an Operational Risk Management solution, improving and streamlining key processes including Permit to Work, Barrier Management, Shift Management and more. eVision software is used by thought leaders across industries, from Shell to Pfizer, and easily scales from single-plant rollouts to full enterprise implementations. For more information, visit www.evision-software.com.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Ossur Hf : Össur acquires College Park Industries19.7.2019 17:00:00 CESTPress release

Reykjavik, 19 July 2019 Össur has signed an agreement to acquire College Park Industries, a global provider of lower and upper limb prostheses and supporting services. College Park has over 140 employees and is headquartered in Detroit, USA. Total sales amounted to USD 22 million in 2018. College Park will largely remain independent and continue to diligently serve its customer base, while allowing the combined entity to achieve strategic efficiencies. Össur is committed to growing the College Park brand over the coming years both in the United States and international markets. Together, both companies will be well-positioned to enhance their offerings in both lower and upper limb prosthetics. With this acquisition, Össur hopes to support College Park’s focus on the lower active population and further strengthen its established presence in the upper limb arena. Mutual access to technology and products will enable a more comprehensive product and service offering to customers around the

Norsk Hydro: REMINDER: Invitation - Hydro’s second quarter results 201919.7.2019 14:43:00 CESTPress release

Hydro's second quarter results 2019 will be released at 07:00 CEST (01:00 AM EDT, 06:00 UK time), on Tuesday July 23, 2019. The quarterly report and presentation slides will be available on www.hydro.com at the same time. Presentation in Oslo Hydro will host a combined analyst and press conference, in English, at its corporate headquarters at Drammensveien 260, Oslo, at 08:30 CEST the same day. The presentation will be held by President and CEO Hilde Merete Aasheim and CFO Eivind Kallevik and can also be seen on web TV. To attend the presentation in Oslo, please register by sending a mail to ir@hydro.com. In addition to the webcast, where it will be possible to ask questions in writing, it will also be possible to dial in (not possible to ask questions over the phone). Dial-in numbers for this conference call are: Norway +47 2100 2610 UK +44 (0)330 336 9125 USA +1 929-477-0324 Sweden +46 (0)8 5033 6574 Brazil +55 11 3181 5427 Germany +49 (0)89 20303 5709 Confirmation Code: 3104804 Q&A

Norsk Hydro: PÅMINNELSE: Invitasjon - Presentasjon av Hydros resultat for andre kvartal 201919.7.2019 14:43:00 CESTPressemelding

Hydros resultat for andre kvartal 2019 blir offentliggjort tirsdag 23. juli 2019 kl. 07.00. Kvartalsrapporten og presentasjonsmaterialet blir samtidig gjort tilgjengelig på www.hydro.com. Presentasjon i Oslo Det blir holdt en kombinert analytikerpresentasjon og pressekonferanse ved Hydros hovedkontor i Drammensveien 260, Oslo, samme dag, kl. 08.30. Resultatet blir presentert av konsernsjef Hilde Merete Aasheim og konserndirektør for Økonomi og finans Eivind Kallevik. Hele presentasjonen kan sees direkte på web-TV. For påmelding, vennligst send mail til ir@hydro.com. I tillegg til web-TV, hvor det vil være mulig å stille spørsmål skriftlig, vil det også være mulig å ringe inn (ikke mulig å stille spørsmål over telefon). Du melder deg på denne telefonkonferansen ved å ringe: Norge +47 2100 2610 UK +44 (0)330 336 9125 USA +1 929-477-0324 Sverige +46 (0)8 5033 6574 Brasil +55 11 3181 5427 Tyskland +49 (0)89 20303 5709 Kode: 3104804 Q&A / Telefonkonferanse Det blir holdt en telefonkonferans

Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma19.7.2019 14:00:00 CESTPressemelding

STOCKHOLM – July 19, 2019. Karolinska Development's portfolio company Forendo Pharma announces today that Sunstone Life Science Ventures joins the existing international investor syndicate and has made a EUR 5 million investment in Forendo Pharma. Claus Andersson, General Partner from Sunstone, joins Forendo Pharma’s Board of Directors. With the investment, Sunstone joins the existing international investor syndicate comprising Novo Seeds, Karolinska Development, Innovestor, Novartis Venture Fund, M Ventures and Vesalius Biocapital Partners. The new financing will enable Forendo Pharma to progress its lead endometriosis program, FOR-6219, an HSD17B1 enzyme inhibitor, into the next phase of clinical studies after the successful completion of its Phase 1a study earlier this year. Endometriosis is a chronic condition that affects many women of reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available treatments for endometriosis have

Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma19.7.2019 14:00:00 CESTPress release

STOCKHOLM – July 19, 2019. Karolinska Development's portfolio company Forendo Pharma announces today that Sunstone Life Science Ventures joins the existing international investor syndicate and has made a EUR 5 million investment in Forendo Pharma. Claus Andersson, General Partner from Sunstone, joins Forendo Pharma’s Board of Directors. With the investment, Sunstone joins the existing international investor syndicate comprising Novo Seeds, Karolinska Development, Innovestor, Novartis Venture Fund, M Ventures and Vesalius Biocapital Partners. The new financing will enable Forendo Pharma to progress its lead endometriosis program, FOR-6219, an HSD17B1 enzyme inhibitor, into the next phase of clinical studies after the successful completion of its Phase 1a study earlier this year. Endometriosis is a chronic condition that affects many women of reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available treatments for endometriosis have